In this study, Ved was determined from V-A coupling (Ees/Ea) measured non-invasively, and whether it could be used as a substitute for Ved measured by echocardiography was investigated. The results showed a significant correlation and compatibility between the two, and it was concluded that Ved from Ees/Ea could be used as a substitute.
Cardiac afterload, such as the involvement of sympathetic nerves from surgical invasion or stimulation, or increased total peripheral vascular resistance, exerts a large effect on blood pressure fluctuations in whole-body management during surgical anesthesia and in the area of intensive care. However, the effect of cardiac preload, such as direct involvement of capacitance vessels or bleeding, is also important. Ved is a direct measure of cardiac preload. However, the direct measurement of Ved is highly invasive.4 Ved can be directly measured with techniques such as cardiac computed tomography, real-time three-dimensional transesophageal echocardiography, or cardiac magnetic resonance imaging,5 but these techniques cannot be used on patients intraoperatively and, depending on the measurement method, can hardly be called noninvasive. Today, stroke volume variation (SVV) and global end-diastolic volume have been commercialized as techniques to monitor cardiac preload,6,7 but a more direct and less invasive method would be preferable. Clinical monitoring for the noninvasive and continuous assessment of Ved does not currently exist. Therefore, a method for noninvasive and continuous monitoring of Ved was devised.
The PEP and ET used in the present study could be noninvasively measured using a vascular screening system (VaSera VS-1000, Fukuda Denshi Co., Ltd, Tokyo, Japan). They can be measured using an oscillometric method with cuffs around both upper arms and both legs. Systolic blood pressure (Ps) and diastolic blood pressure (Pd) are also displayed. In addition, according to the study of Kappus et al., a substitution equation that uses Ps and Pd can be used for Ped.3
Further study is needed to compare the utility of the Ved from the present method and SVV based on invasive arterial pressure waveform analysis. However, though with SVV the effects on SV of fluctuations in intrathoracic pressure from artificial respiration are quantified and monitored, the present method is an index that is unrelated to artificial respiration and so will have widespread clinical applications; for example, it can be used even in patients who are awake during intensive care.
SV measured with transthoracic ultrasonography was used in this study. However, in the future, it will be possible to measure Ved continuously by using a method that predicts SV noninvasively from estimated continuous cardiac output.8
Study limitations
The present study has several limitations. First, V0 was assumed to be zero with the present method. Since the actual value is V0 plus a calculated value, the calculated value should theoretically be smaller than the actual value, and, especially in patients whose V0 is significantly large, such as in those with dilated cardiomyopathy, it is thought that the calculated value will be underestimated with respect to the actual value.
Second, the subjects in the present study were young, healthy people with normal cardiac function. In a past report,9 Ved in Japanese persons in their 20s and 30s was about 100 ml, and so in the present study, subjects with Ved ≥ 140 ml were excluded. In the future, it will be necessary to investigate whether there is a similar correlation and compatibility between Ved echo and Ved calc in patients with Ved ≥ 140 ml and patients with decreased cardiac function.
Third, the subjects in the present study were not intubated and had spontaneous respiration. Whether there is also a similar correlation and compatibility between Ved echo and Ved calc in patients under general anesthesia and those who are intubated will need to be investigated.